Dr. Hedy Kindler, M.D.
Claim this profileUniversity of Chicago Comprehensive Cancer Center
Expert in Mesothelioma
Expert in Malignant Pleural Mesothelioma
17 reported clinical trials
30 drugs studied
Area of expertise
1Mesothelioma
Global LeaderStage IV
Stage III
ARID1A positive
2Malignant Pleural Mesothelioma
Global LeaderStage IV
Stage III
ARID1A positive
Affiliated Hospitals
Clinical Trials Hedy Kindler, M.D. is currently running
TNG462
for Solid Cancers
This trial is testing a new oral drug called TNG462 in patients with advanced or metastatic solid tumors that have an MTAP deletion. The drug works by blocking a protein that helps these cancer cells grow. The goal is to see if TNG462 can stop the cancer from growing and spreading.
Recruiting1 award Phase 1 & 2
Olaparib
for Pancreatic Cancer
This phase II trial investigates how well the addition of olaparib following completion of surgery and chemotherapy works in treating patients with pancreatic cancer that has been surgically removed (resected) and has a pathogenic mutation in BRCA1, BRCA2, or PALB2. Olaparib is an inhibitor of PARP, an enzyme that helps repair deoxyribonucleic acid (DNA) when it becomes damaged. Blocking PARP may help keep tumor cells from repairing their damaged DNA, causing them to die. PARP inhibitors are a type of targeted therapy.
Recruiting0 awards Phase 232 criteria
More about Hedy Kindler, M.D.
Clinical Trial Related4 years of experience running clinical trials · Led 17 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Hedy Kindler, M.D. has experience with
- Pemetrexed
- Cisplatin
- Carboplatin
- Pamrevlumab
- Gemcitabine
- Pembrolizumab
Breakdown of trials Hedy Kindler, M.D. has run
Mesothelioma
Malignant Pleural Mesothelioma
Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Hedy Kindler, M.D. specialize in?
Hedy Kindler, M.D. focuses on Mesothelioma and Malignant Pleural Mesothelioma. In particular, much of their work with Mesothelioma has involved Stage IV patients, or patients who are Stage III.
Is Hedy Kindler, M.D. currently recruiting for clinical trials?
Yes, Hedy Kindler, M.D. is currently recruiting for 8 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Hedy Kindler, M.D. has studied deeply?
Yes, Hedy Kindler, M.D. has studied treatments such as Pemetrexed, Cisplatin, Carboplatin.
What is the best way to schedule an appointment with Hedy Kindler, M.D.?
Apply for one of the trials that Hedy Kindler, M.D. is conducting.
What is the office address of Hedy Kindler, M.D.?
The office of Hedy Kindler, M.D. is located at: University of Chicago Comprehensive Cancer Center, Chicago, Illinois 60637 United States. This is the address for their practice at the University of Chicago Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.